早期非小细胞肺癌立体定向放疗中国专家共识(2019版)  

Chinese expert consensus on stereotactic body radiation therapy for early stage non-small cell lung cancer(2019 Edition)

作　　者：无 邢力刚[4] 无;Xing Ligang(Radiation Oncology Branch of Chinese Medical Association;Radiation Therapy Committee of China Anti-Cancer Association;Radiation Oncologist Branch of Chinese Medical Doctor Association;Department of Radiation Oncology,Shandong First Medical University Affiliated Cancer Hospital Shandong Cancer Hospital,Jinan 250117,China)

机构地区：[1]中华医学会放射肿瘤治疗学分会 [2]中国抗癌协会肿瘤放射治疗学专业委员会 [3]中国医师协会放射治疗医师分会 [4]山东第一医科大学附属肿瘤医院,山东省肿瘤医院放疗科,济南250117

出　　处：《中华肿瘤杂志》2020年第7期522-530,共9页Chinese Journal of Oncology

基　　金：国家重点研发计划(2018YFC1313220)。

摘　　要：立体定向体部放射治疗(SBRT)已成为早期非小细胞肺癌的重要根治性手段,尤其在不可手术或拒绝外科手术的患者中是首选治疗手段。在中国,SBRT正在普及,为了规范临床应用、推动技术水平提升和科研协作,特制定本专家共识。共识包括SBRT发展简介、物理技术要求、临床实施规范和特殊临床问题等,期望本共识在临床实践中可以为临床医师提供指导以及造福于广大肺癌患者。Stereotactic body radiation therapy(SBRT)has become an important radical approach for early stage non-small cell lung cancer,especially for patients who are inoperable or refuse surgery.In China,this precision radiotherapy technology is being popularized.In order to standardize clinical application,improve the cooperation of technology and scientific research,this expert consensus is established.The consensus includes a brief introduction to the development of SBRT,the physical and technical requirements,the clinical implementation standardization and special clinical problems.The promotion and application of the consensus in clinical practice and constantly updated according to the latest research results will benefit more and more lung cancer patients.

关 键 词：癌 非小细胞肺 立体定向放疗 专家共识 

分 类 号：R734.2[医药卫生—肿瘤]